Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5274 ARTÍCULOS , VIENDO DEL 961 AL 975

Development and validation of anti-human Alpha synuclein DNA aptamer using computer modelling techniques-an in silico study

Rock M, Zouganelis GD, de Andrade AFB, Drake SJ, Alexiou A, Albrakati A, Batiha GE, Illingworth TA.

J Integr Neurosci. 2022 Jan 21;21(1):5. doi: 10.31083/j.jin2101005.

Review of the recruitment process for a large investigator-initiated trial in early Parkinson's disease

Verschuur CVM, Donovan JL, de Bie RMA.

Trials. 2022 Feb 14;23(1):141. doi: 10.1186/s13063-022-06052-y.

Antemortem detection of Parkinson's disease pathology in peripheral biopsies using artificial intelligence

Signaevsky M, Marami B, Prastawa M, Tabish N, Iida MA, Zhang XF, Sawyer M, Duran I, Koenigsberg DG, Bryce CH, Chahine LM, Mollenhauer B, Mosovsky S, Riley L, Dave KD, Eberling J, Coffey CS, Adler CH, Serrano GE, White CL 3rd, Koll J, Fernandez G, Zeineh J, Cordon-Cardo C, Beach TG, Crary JF.

Acta Neuropathol Commun. 2022 Feb 14;10(1):21. doi: 10.1186/s40478-022-01318-7.

The Impact of COVID-19 On Comorbidities: A Review Of Recent Updates For Combating It

Ahmad Malik J, Ahmed S, Shinde M, Almermesh MHS, Alghamdi S, Hussain A, Anwar S.

Saudi J Biol Sci. 2022 May;29(5):3586-3599. doi: 10.1016/j.sjbs.2022.02.006. Epub 2022 Feb 10.

Neuromelanin-MRI to Quantify and Track Nigral Depigmentation in Parkinson's Disease: A Multicenter Longitudinal Study Using Template-Based Standardized Analysis

Xing Y, Sapuan AH, Martín-Bastida A, Naidu S, Tench C, Evans J, Sare G, Schwarz ST, Al-Bachari S, Parkes LM, Kanavou S, Raw J, Silverdale M, Bajaj N, Pavese N, Burn D, Piccini P, Grosset DG, Auer DP.

Mov Disord. 2022 May;37(5):1028-1039. doi: 10.1002/mds.28934. Epub 2022 Feb 15.

Recent Update on the Development of Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors: A Promising Target for the Treatment of Parkinson's Disease

Patel A, Patel S, Mehta M, Patel Y, Langaliya D, Bhalodiya S, Bambharoliya T.

Med Chem. 2022;18(7):757-771. doi: 10.2174/1573406418666220215122136.

Drug-induced Delusional Infestation

Kemperman PMJH, Bruijn TVM, Vulink NCC, Mulder MMC.

Acta Derm Venereol. 2022 Mar 8;102:adv00663. doi: 10.2340/actadv.v102.183.

Stem cell therapy for COVID-19 pneumonia

Kebria MM, Milan PB, Peyravian N, Kiani J, Khatibi S, Mozafari M.

Mol Biomed. 2022 Feb 17;3(1):6. doi: 10.1186/s43556-021-00067-8.

Dynamic interplay of cognitive functioning and depressive symptoms in patients with Parkinson's disease

Schroeders U, Zimmermann J, Wicke T, Schaumburg M, Lang E, Trenkwalder C, Mollenhauer B.

Neuropsychology. 2022 May;36(4):266-278. doi: 10.1037/neu0000795. Epub 2022 Feb 17.

Effect of home-based virtual reality training and telerehabilitation on balance in individuals with Parkinson disease, multiple sclerosis, and stroke: a systematic review and meta-analysis

Truijen S, Abdullahi A, Bijsterbosch D, van Zoest E, Conijn M, Wang Y, Struyf N, Saeys W.

Neurol Sci. 2022 May;43(5):2995-3006. doi: 10.1007/s10072-021-05855-2. Epub 2022 Feb 17.

A telephonic survey of health-related quality of life of outpatient department dropout Parkinson's disease patients during the COVID-19 pandemic

Goel A, Narayan SK, Sugumaran R.

Acta Neurol Belg. 2022 Apr;122(2):519-523. doi: 10.1007/s13760-022-01891-7. Epub 2022 Feb 17.

Is there a need for a novel algorithm for accessory pathways localization?

Nayfeh M, Refaat MM.

J Cardiovasc Electrophysiol. 2022 May;33(5):962-965. doi: 10.1111/jce.15414. Epub 2022 Feb 26.

The role of the locus coeruleus/norepinephrine system in the pathogenesis of neurodegenerative disorders: An update

Malatt C, Tagliati M.

Curr Opin Neurol. 2022 Apr 1;35(2):220-229. doi: 10.1097/WCO.0000000000001042.

α-Synuclein in Parkinson's disease and advances in detection

Chen R, Gu X, Wang X.

Clin Chim Acta. 2022 Apr 1;529:76-86. doi: 10.1016/j.cca.2022.02.006. Epub 2022 Feb 14.

Rodent models for gait network disorders in Parkinson's disease - a translational perspective

Wenger N, Vogt A, Skrobot M, Garulli EL, Kabaoglu B, Salchow-Hömmen C, Schauer T, Kroneberg D, Schuhmann MK, Ip CW, Harms C, Endres M, Isaias IU, Tovote P, Blum R.

Exp Neurol. 2022 Jun;352:114011. doi: 10.1016/j.expneurol.2022.114011. Epub 2022 Feb 14.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias